Conagen’s Grant Award Opens New Markets for Monoclonal Antibodies
March 29, 2022
Funding from the Bill & Melinda Gates Foundation for Conagen’s Conamax platform benefits developing countries and patients globally. Bedford, Mass., March 29, 2022 (GLOBE NEWSWIRE)